Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $11.70 $16.59 Friday, 10th May 2024 NVCR stock ended at $16.47. This is 2.11% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.56% from a day low at $16.02 to a day high of $16.59.
90 days $11.70 $18.04
52 weeks $10.87 $83.60

Historical NovoCure Limited prices

Date Open High Low Close Volume
Feb 29, 2024 $16.32 $16.45 $15.14 $15.31 1 339 020
Feb 28, 2024 $16.23 $16.47 $15.96 $16.02 926 561
Feb 27, 2024 $15.18 $16.48 $15.18 $16.30 1 357 370
Feb 26, 2024 $15.14 $15.24 $14.70 $14.90 1 215 233
Feb 23, 2024 $15.10 $15.76 $14.86 $15.22 1 436 645
Feb 22, 2024 $16.98 $17.00 $14.50 $15.24 1 305 916
Feb 21, 2024 $15.77 $15.77 $15.16 $15.62 987 661
Feb 20, 2024 $16.05 $16.24 $15.60 $15.82 1 125 831
Feb 16, 2024 $15.71 $16.99 $15.54 $16.14 1 356 013
Feb 15, 2024 $15.76 $16.15 $15.28 $15.93 783 724
Feb 14, 2024 $15.24 $15.73 $15.01 $15.62 1 008 668
Feb 13, 2024 $15.31 $15.64 $14.75 $14.92 881 539
Feb 12, 2024 $15.33 $16.14 $15.29 $16.10 1 054 477
Feb 09, 2024 $15.01 $15.40 $14.81 $15.31 1 098 441
Feb 08, 2024 $14.85 $15.47 $14.65 $14.85 972 820
Feb 07, 2024 $15.00 $15.48 $14.63 $14.96 963 061
Feb 06, 2024 $13.78 $14.88 $13.55 $14.87 995 705
Feb 05, 2024 $13.90 $13.93 $13.45 $13.73 872 206
Feb 02, 2024 $14.35 $14.35 $13.65 $14.10 806 041
Feb 01, 2024 $14.01 $14.76 $13.91 $14.66 756 272
Jan 31, 2024 $14.09 $14.62 $13.92 $13.92 1 050 204
Jan 30, 2024 $15.24 $15.24 $13.95 $14.02 1 026 328
Jan 29, 2024 $14.01 $15.52 $13.68 $15.49 1 200 220
Jan 26, 2024 $13.80 $14.22 $13.64 $14.21 745 631
Jan 25, 2024 $14.14 $14.30 $13.61 $13.69 762 755
Click to get the best stock tips daily for free!

About NovoCure Limited

NovoCure Limited NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed c... NVCR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT